Compound ID | 2435
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. Bacterial topoisomerase inhibitor |
| Target Pathogen: | Active against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa |
| Description: | Synthetic compound; with efficacy comparative to levofloxacin on Acinetobacter baumannii infection in neutropenic mouse thigh model; analogues reported |
| Institute where first reported: | State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China |
| Year first mentioned: | 2021 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/168276334 |
| Citation: | https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00621 |